FDA panel backs half-dose Moderna booster for the elderly and others at high risk kdunleavy Thu, 10/14/2021 – 17:00 More: FDA panel backs half-dose Moderna booster for the elderly and others at high risk Source: fierce
read moreRegeneron pushes its versatile antibody cocktail closer to finish line as a multi-use COVID treatment kdunleavy Thu, 10/14/2021 – 13:57 More: Regeneron pushes its versatile antibody cocktail closer to finish line as a multi-use COVID treatment Source: fierce
read moreA return to the top: Former FDA Commissioner Califf reportedly Biden’s pick for Woodcock’s role klahucik Thu, 10/14/2021 – 13:52 More: A return to the top: Former FDA Commissioner Califf reportedly Biden's pick for Woodcock's role Source: fierce
read moreEntry closes on 22nd October – so don’t miss out on your chance to enter now More: Entry still open for 2021 Marketer of the Year, Sales and Communications Awards! Source: News
read moreMerck bags imperfect immunotherapy first with Keytruda cervical cancer approval aliu Thu, 10/14/2021 – 10:27 More: Merck bags imperfect immunotherapy first with Keytruda cervical cancer approval Source: fierce
read moreBristol Myers Squibb is nixing BeiGene’s Abraxane deal in China amid manufacturing woes. Is their cancer rivalry really to blame? aliu Thu, 10/14/2021 – 09:34 More: Bristol Myers Squibb is nixing BeiGene's Abraxane deal in China amid manufacturing woes. Is
read more© 1994 - 2026 B.M. Pharmaceuticals